Overview
This is the 12th DIA Middle East Regulatory Conference (MERC) in partnership with the Middle East Regulatory Network (MERN). The conference will bring together most authorities from the Middle East region and discuss the hot topics in the region, such as serialisation and life cycle management. Recent developments at country-level are also discussed. This conference is one of its kind and takes place biennially. It has grown rapidly over the past years and early registration is recommended.
Our Middle East Regulatory Conference programme committee, pulled together their thoughts on regulatory progress made in countries across the region. Examples include: Issue of fast track regulation in Egypt, and Update on pricing regulations in Lebanon. View Infographic
View the Global Forum articles from the 2013 MERC & 2015 MERC
Featured topics
The programme is under development and will be updated frequently. We recommend visiting the page for updates.
Who should attend?
The conference offers the opportunity for key stakeholders active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.
Program Committee
-
Kerstin Ahrendt-Soelter • Director Regulatory Affairs International
Biotest AG, Germany -
Donia Al Bastaki • Head of Registration Department, Pharmaceutical & Herbal Medicines Registration
Ministry of Health, Drug and Food Control, Kuwait -
Tamara Al Rabi • Country Regulatory Head
Pfizer, Jordan -
Haitham Saad Al-Zuhair • Regulatory Affairs Director
Janssen-Cilag, Saudi Arabia -
Hassaan S Alwohaibi • Director of Products Licensing Department - Executive Department of Licensing
Saudi Food and Drug Authority, Saudi Arabia -
Ihab Attia • Regulatory Affairs Director - Middle East Affiliate
Eli Lilly (suisse) S.A., United Arab Emirates -
Adele Choueiry • Head, Regulatory Affairs, Levant Region; Lebanon Regulatory Working Group Chair
Novartis , Lebanon -
Paul Dearden • Director, Regulatory Policy & Intelligence
AbbVie, United Kingdom -
Greg Jordinson, MSc • Associate Director, Global Regulatory Affairs
Janssen R&D, United Kingdom -
Mounay Hussein Khafaja, PharmD, MSc • Regulatory Affairs Director & Regulatory Center of Excellence, IRWG Group Chair
Merck, Lebanon -
Sarah Maqseed • Health Authority Advisors
KFDA Kuwait Drug and Food Control Administration, Kuwait -
Samia Gamal Seleem, PharmD, RAC • Scientific office & Regulatory Affairs
Abbvie, Egypt -
Marloes van Bruggen, MS • Regulatory Program Manager
F.Hoffmann-La Roche Ltd., Switzerland -
Nadine Otin •
LEEM, France
